glp 1 houston Medical Weight Loss Texas Houston Weight Loss Center |

March 18 Product: Orchard Therapeutics Lenmeldy Indication: Metachromatic leukodystrophy Monday, the FDA gave a glimmer of hope to families of children with metachromatic leukodystrophy (MLD), a rare genetic disease affecting the brain and nervous system, with the approval of Orchard Therapeutics Lenmeldy

However, genetic predisposition does not predict exact medication response

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 49 peptides across 14 pathways, identifying variants like GLP1R rs6923761 and MC4R rs17782313 that predict your response to semaglutide and other GLP-1 agonists

Hwang E, Portillo B, Williams KW.New Science Translational Medicine

This knowledge is essential for crafting a personalized plan that maximizes results and enhances your health journey

GLP-1 medications slow gastric emptying and increase insulin secretion in response to food, helping regulate post-meal glucose spikes